The FDA is working to address a shortage of intravenous (IV) solutions, particularly 0.9% Sodium Chloride Injection. The agency is working with three manufacturers of IV solutions: Baxter, B. Braun Medical, and Hospira to help preserve the supply of these products.
The shortage may have been triggered by an increased use of these solutions in hospitals, possibly related to the flu season. Baxter announced that their products are on allocation and they are working to maximize product availability. Hospira announced their shortage is due to manufacturing delays.
IV solutions provide necessary hydration to patients in various medical situations. They provide replacement and maintenance of fluids and electrolytes in patients unable to take their daily water and salt needs by mouth. IV solutions can also serve as a vehicle for other medications in IV admixture preparations.
For more information call (888) 463-6332 or visit the FDA Drug Shortage website.